Recombinant Human LILRA2 Protein

Leader in Biomolecular Solutions for Life Science Recombinant Human LILRA2 Protein

Catalog No.: RP02159 Recombinant

Sequence Information Background

Species Gene ID Swiss Prot Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2) is a single- Human 11027 Q8N149 pass type I membrane protein. LILRA2 is expressed predominantly on monocytes and B cells, and at lower levels on dendritic cells and natural killer cells. LILRA2 contains Tags four Ig-like C2-type domains, with short cytoplasmic domains lacking an C-6×His immunoreceptor tyrosine-based inhibitory motif (ITIM) and with transmembrane regions containing a charged arginine residue, may initiate stimulatory cascades. LILRA2 does not bind class I MHC antigens. Synonyms CD85H; ILT1; LIR-7; LIR7 Basic Information

Description Recombinant Human LILRA2 Protein is produced by Mammalian expression system. The target protein is expressed with sequence (Gly24-Ser420) of human LILRA2 Product Information (Accession #Q8N149-2) fused with a 6xHis tag at the C- terminus.

Source Puriﬁcation Bio-Activity Mammalian > 95% by SDS- PAGE. Storage Store the lyophilized protein at -20°C to -80 °C for long term. Endotoxin After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for < 1 EU/μg of the protein by LAL method. up to 1 week. Avoid repeated freeze/thaw cycles. Formulation Lyophilized from a 0.2 μm ﬁltered solution of 20mM PB, 150mM NaCl, pH 7.4.Contact us for customized product form or formulation.

Reconstitution Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.

Contact

400-999-6126

[email protected]

www.abclonal.com.cn Validation Data

Recombinant Human LILRA2 Protein was determined by SDS-PAGE with Coomassie Blue, showing a band at 66kDa.